22 Mar 2022 --- A wide-ranging commission has been created to review regulation and public policy around the UK’s legal cannabis industry, which includes consumer cannabinoids in wellness products. Backed by the Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI) and First November Group, the commission’s final report will be published in May 2022.
